Secondary prevention in a large stroke population: A study of patientsg' purchase of recommended drugs

Stroke

Volumn 39, Issue 10, 2008, Pages 2880-2885

  Wettermark, Björn ^a,d   Persson, Anna ^c   Von Euler, Mia ^b  

^a Department of Laboratory Medicine ^*  (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Drug therapy; Guidelines; Secondary prevention; Stroke; TIA

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; THIAZIDE DIURETIC AGENT; WARFARIN; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

AGED; ARTICLE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PURCHASING; SECONDARY PREVENTION; STROKE; STROKE PATIENT; SWEDEN; TRANSIENT ISCHEMIC ATTACK; ADULT; AGE; LETTER; MIDDLE AGED; PATIENT COMPLIANCE; SEX DIFFERENCE; STATISTICS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; SEX FACTORS; STROKE; SWEDEN;

EID: 54049084972     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.513390     Document Type: Article

References (15)

1. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or TIA. Stroke. 2006;37: 577-617.
2. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
3. Micieli G, Cavallini A,Quaglini S. Guideline compliance improves stroke outcome. Stroke. 2002;33:1341-1347.
4. Duffy BK, Phillips PA, Davis SM, Donnan GA, Vedadhaghi ME; Stroke in Hospitals: an Australian Review of Treatment investigators. Evidence-based care and outcomes of acute stroke managed in hospital speciality units. MJA. 2003;178:318-323.
5. Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, De Reuck J, Mas JL, Gallai V; SAFE II Investigators. Stroke prevention and atrial fibrillation. Main results of the SAFE II study. Br J Clin Pharmacol. 2004; 57:798-806.
6. Gibbs RG, Newson R, Lawrenson R, Greenhalgh RM, Davies AH. Diagnosis and initial management of stroke and TIA across UK health regions from 1992-96. Stroke. 2001;32:1085-1090.
7. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke: A prospective Evaluation. Stroke. 2001;32:1884-1889.
8. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M. The new Swedish Prescribed Drug Register. Pharmacoepidemiol Drug Saf. 2007;16:726-735.
9. National Board of Health and Welfare. Stroke care in Sweden. Stockholm 2007.
10. http://www.riks-stroke.org.
11. Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G. Secondary prevention of stroke in Italy. Stroke. 2003;34:1010-1014.
12. Volpato S, Maraldi C, Blè A, Ranzini M, Rita Atti A, Dominguez LJ, Barbagallo M, Fellin R, Zuliani G; Gruppo Italiano di Farmacoepide-miologia nell'Anziano (GIFA). Prescription of antithrombotic therapy in older patients hospitalised for TIA and ischemic stroke: the GIFA study. Stroke. 2004;35:913.
13. Andersen KK, Olsen TS. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants. Stroke. 2007;38: 259-263.
14. Swedish Council on Technology Assessment in Health Care (SBU). Moderately Elevated Blood Pressure. SBU report 170, 2004. Stockholm, 2004.
15. Ovbiagele B, Saver JL, Bang H, Chambless LE, Nassief A, Minuk J, Toole JF, Crouse JR; VISP Study Investigators. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology. 2006;66: 1164-1170.